Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

October 17, 2018 admin CEO Interview, Healthcare Comments Off on Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., discusses cannabinoid-based drug pipeline.

tetra logo

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Guy Chamberland

 

 

 

 

 

Tetra Bio-Pharma (TSX: TBP) (OTC: TBPMF) CEO Guy Chamberland, Ph.D., shares update on Tetra’s Cannabinoid-based drug pipeline as opioid alternative.

Investor Presentation Deck
Tetra Investor Presentation




Related Articles

Newsmakers

Yield Growth (OTC: BOSQF) Files PCT Patent for Cannabis Root Extraction Method for Key Ingredient in 150 Proprietary Beauty and Wellness Formulas

April 17, 2019 admin Newsmakers Comments Off on Yield Growth (OTC: BOSQF) Files PCT Patent for Cannabis Root Extraction Method for Key Ingredient in 150 Proprietary Beauty and Wellness Formulas

VANCOUVER, British Columbia, April 16, 2019 — The Yield Growth Corp. CSE: BOSS) (OTC: BOSQF) (frankfurt:YG3) announces it has filed a patent application to protect its inventions for hemp root oil production and its use in […]

CEO Interview

Hill Street Beverage Company (CSE: BEER) (OTC: HSEEF) Leveraging alcohol-free wine and beer into cannabis market

May 17, 2019 admin CEO Interview, Consumer Comments Off on Hill Street Beverage Company (CSE: BEER) (OTC: HSEEF) Leveraging alcohol-free wine and beer into cannabis market

  Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]

Healthcare

FDA Grants Face-to-Face Meeting to Discuss CytoDyn’s (OTC: CYDY) 510(k) Application for ProstaGene(TM) Prognostic Test

June 24, 2019 admin Healthcare, Newsmakers Comments Off on FDA Grants Face-to-Face Meeting to Discuss CytoDyn’s (OTC: CYDY) 510(k) Application for ProstaGene(TM) Prognostic Test

VANCOUVER, Washington, June 24, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications today announced that […]